Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● From a short-term investment perspective, the company presents a deteriorated fundamental situation

● The company has a good ESG score relative to its sector, according to MSCI.


Strengths

● The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● The company is in a robust financial situation considering its net cash and margin position.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.


Weaknesses

● The company benefits from high valuations in earnings multiples.

● Based on current prices, the company has particularly high valuation levels.

● In relation to the value of its tangible assets, the company's valuation appears relatively high.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● Most analysts recommend that the stock should be sold or reduced.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.